[{"source": "PMC", "date": "20240203", "key": "pmc.key", "infons": {}, "documents": [{"id": "10755264", "infons": {"license": "CC BY"}, "passages": [{"offset": 0, "infons": {"article-id_doi": "10.12688/f1000research.133899.3", "article-id_pmc": "10755264", "article-id_pmid": "38161428", "elocation-id": "810", "fn": "[version 3; peer review: 1 approved", "kwd": "Uniprot ID P02649 APOE Apolipoprotein E antibody characterization antibody validation Western Blot immunoprecipitation", "license": "This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.", "name_0": "surname:Ayoubi;given-names:Riham", "name_1": "surname:Southern;given-names:Kathleen", "name_2": "surname:Laflamme;given-names:Carl", "sec": "In this new version, Figure 1 has been updated to repeat Western blot testing for antibodies\u00a0ab1907* and\u00a0MA5-15852* to determine whether they would successfully target ApoE when using a dilution of 1/200 rather than 1/1000. Table 1 was also updated. The title was also amended.", "section_type": "TITLE", "title": "Amendments from Version 2", "type": "front", "volume": "12", "year": "2023"}, "text": "Identification of high-performing antibodies for Apolipoprotein E for use in Western Blot and immunoprecipitation", "sentences": [], "annotations": [], "relations": []}, {"offset": 114, "infons": {"section_type": "ABSTRACT", "type": "abstract"}, "text": "Apolipoprotein E is a secreted protein involved in mediating lipid distribution and metabolism among cells of specific tissues. The dysregulation of Apolipoprotein E can disturb cholesterol homeostasis, resulting in several diseases, including cardiovascular disease and Alzheimer\u2019s disease. The therapeutic potential of Apolipoprotein E against these diseases demonstrates the importance of providing high-quality antibodies for this protein to the scientific community. In this study, we characterized fourteen Apolipoprotein E commercial antibodies for Western Blot and immunoprecipitation, using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. We identified many high-performing antibodies and encourage readers to use this report as a guide to select the most appropriate antibody for their specific needs.", "sentences": [], "annotations": [], "relations": []}, {"offset": 1001, "infons": {"section_type": "INTRO", "type": "title_1"}, "text": "Introduction", "sentences": [], "annotations": [], "relations": []}, {"offset": 1014, "infons": {"section_type": "INTRO", "type": "paragraph"}, "text": "Apolipoprotein E, or APOE, is a 299 amino acid transcribed and secreted to regulate lipid homeostasis by controlling the uptake of cholesterol and lipoproteins via receptor-mediated endocytosis.    ,    Three major isoforms of APOE exist, apoE4, apoE3, and apoE2.    Despite only differing by single amino acid substitutions, their functionalities are altered at both the cellular and molecular levels.    Accordingly, the binding affinity of APOE to its ligand, the LDL receptor (LDLR), varies depending on the isoform.    ApoE3 and apoE4 bind to LDLR with high affinity while apoE2 binds with low affinity.    ", "sentences": [], "annotations": [], "relations": []}, {"offset": 1627, "infons": {"section_type": "INTRO", "type": "paragraph"}, "text": "Association studies have demonstrated apoE4 to be a genetic risk factor for cardiovascular disease, as it can cause high levels of circulating cholesterol, in the form of LDL as well as a genetic risk factor for late-onset Alzheimer\u2019s disease.    \u2013    The critical role of APOE in health and disease highlights the need for additional research into the protein\u2019s mechanism of action and potential for therapeutic strategies.    Mechanistic studies would be greatly facilitated with the availability of validated and high-quality antibodies.", "sentences": [], "annotations": [], "relations": []}, {"offset": 2174, "infons": {"section_type": "INTRO", "type": "paragraph"}, "text": "Here, we compared the performance of a range of commercially-available antibodies for Apolipoprotein E and validated several antibodies for Western Blot and immunoprecipitation, enabling biochemical and cellular assessment of Apolipoprotein E properties and function.", "sentences": [], "annotations": [], "relations": []}, {"offset": 2442, "infons": {"section_type": "RESULTS", "type": "title_1"}, "text": "Results and discussion", "sentences": [], "annotations": [], "relations": []}, {"offset": 2465, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "Our standard protocol involves comparing readouts from wild-type (WT) and knockout (KO) cells.    \u2013    The first step was to identify a cell line(s) that expresses sufficient levels of Apolipoprotein E to generate a measurable signal. To this end, we examined the DepMap transcriptomics database to identify all cell lines that express the target at levels greater than 2.5 log 2 (transcripts per million \u201cTPM\u201d + 1), which we have found to be a suitable cut-off (Cancer Dependency Map Portal, RRID:SCR_017655). Commercially available HAP1 cells expressed the APOE transcript at RNA levels above the average range of cancer cells analyzed. Parental and APOE knockout HAP1 cells were obtained from Horizon Discovery ( Table 1).", "sentences": [], "annotations": [], "relations": []}, {"offset": 3197, "infons": {"file": "T1.xml", "id": "T1", "section_type": "TABLE", "type": "table_title_caption"}, "text": "Summary of the cell lines used.", "sentences": [], "annotations": [], "relations": []}, {"offset": 3229, "infons": {"file": "T1.xml", "id": "T1", "section_type": "TABLE", "type": "table", "xml": "<?xml version=\"1.0\" encoding=\"UTF-8\"?>\n<table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\" content-type=\"article-table\"><thead><tr><th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Institution</th><th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Catalog number</th><th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">RRID (Cellosaurus)</th><th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Cell line</th><th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Genotype</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Horizon Discovery</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">C631</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">\n<ext-link xlink:href=\"https://www.cellosaurus.org/CVCL_Y019\" ext-link-type=\"uri\">CVCL_Y019</ext-link>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">HAP1</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">WT</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Horizon Discovery</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">HZGHC005366c001</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">\n<ext-link xlink:href=\"https://www.cellosaurus.org/CVCL_SC97\" ext-link-type=\"uri\">CVCL_SC97</ext-link>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">HAP1</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">\n<italic toggle=\"yes\">APOE</italic> KO (16bp deletion)</td></tr></tbody></table>\n"}, "text": "Institution\tCatalog number\tRRID (Cellosaurus)\tCell line\tGenotype\t \tHorizon Discovery\tC631\tCVCL_Y019\tHAP1\tWT\t \tHorizon Discovery\tHZGHC005366c001\tCVCL_SC97\tHAP1\tAPOE KO (16bp deletion)\t \t", "sentences": [], "annotations": [], "relations": []}, {"offset": 3415, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "Apolipoprotein E is predicted to be a secreted protein. Accordingly, we collected concentrated culture media from both WT and APOE KO cells and used the conditioned media to probe the performance of the antibodies ( Table 2) side-by-side by Western Blot and immunoprecipitation.    ,    The profiles of the tested antibodies are shown in Figures 1 and 2.", "sentences": [], "annotations": [], "relations": []}, {"offset": 3770, "infons": {"file": "T2.xml", "id": "T2", "section_type": "TABLE", "type": "table_title_caption"}, "text": "Summary of the Apolipoprotein E antibodies tested.", "sentences": [], "annotations": [], "relations": []}, {"offset": 3821, "infons": {"file": "T2.xml", "id": "T2", "section_type": "TABLE", "type": "table", "xml": "<?xml version=\"1.0\" encoding=\"UTF-8\"?>\n<table xmlns:xlink=\"http://www.w3.org/1999/xlink\" frame=\"hsides\" rules=\"groups\" content-type=\"article-table\"><thead><tr><th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Company</th><th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Catalog number</th><th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Lot number</th><th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">RRID (Antibody Registry)</th><th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Clonality</th><th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Immunogenic region</th><th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Clone ID</th><th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Host</th><th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Concentration (\u03bcg/\u03bcL)</th><th align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"top\">Vendors recommended applications</th></tr></thead><tbody><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">GeneTex</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">GTX635889\n<xref rid=\"tfn1\" ref-type=\"table-fn\">*</xref>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">44195</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">\n<ext-link xlink:href=\"https://antibodyregistry.org/search?q=AB_2909916\" ext-link-type=\"uri\">AB_2909916</ext-link>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">monoclonal</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">proprietary information</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">GT27711</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">mouse</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">1.0</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Wb</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">GeneTex</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">GTX635891\n<xref rid=\"tfn1\" ref-type=\"table-fn\">*</xref>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">44195</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">\n<ext-link xlink:href=\"https://antibodyregistry.org/search?q=AB_2909917\" ext-link-type=\"uri\">AB_2909917</ext-link>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">monoclonal</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">proprietary information</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">GT1627</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">mouse</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">1.0</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Wb</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Abcam</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">ab52607\n<xref rid=\"tfn2\" ref-type=\"table-fn\">**</xref>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">GR33789797</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">\n<ext-link xlink:href=\"https://antibodyregistry.org/search?q=AB_867704\" ext-link-type=\"uri\">AB_867704</ext-link>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">recombinant-mono</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">proprietary information</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">EP1374Y</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">rabbit</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">0.1</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Wb, IP, IF</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Abcam</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">ab51015\n<xref rid=\"tfn2\" ref-type=\"table-fn\">**</xref>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">GR19880919</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">\n<ext-link xlink:href=\"https://antibodyregistry.org/search?q=AB_867703\" ext-link-type=\"uri\">AB_867703</ext-link>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">recombinant-mono</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">proprietary information</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">EP1373Y</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">rabbit</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">0.14</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Wb, IP, IF</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Abcam</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">ab1907\n<xref rid=\"tfn1\" ref-type=\"table-fn\">*</xref>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">GR33619625</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">\n<ext-link xlink:href=\"https://antibodyregistry.org/search?q=AB_302669\" ext-link-type=\"uri\">AB_302669</ext-link>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">monoclonal</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">polymorphic amino acid 158</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">E6D7</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">mouse</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">1.0</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">IF</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Cell Signaling Technology</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">13366\n<xref rid=\"tfn2\" ref-type=\"table-fn\">**</xref>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">4</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">\n<ext-link xlink:href=\"https://antibodyregistry.org/search?q=AB_2798191\" ext-link-type=\"uri\">AB_2798191</ext-link>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">recombinant-mono</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">proprietary information</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">D7I9N</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">rabbit</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">n/a</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Wb, IP, IF</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Aviva Systems Biology</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">ARP54283</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">QC56479-160608</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">\n<ext-link xlink:href=\"https://antibodyregistry.org/search?q=AB_10640958\" ext-link-type=\"uri\">AB_10640958</ext-link>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">polyclonal</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">N-terminal </td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">-</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">rabbit</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">0.5</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Wb</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Thermo Fisher Scientific</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">701241\n<xref rid=\"tfn2\" ref-type=\"table-fn\">**</xref>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">2477346</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">\n<ext-link xlink:href=\"https://antibodyregistry.org/search?q=AB_2532438\" ext-link-type=\"uri\">AB_2532438</ext-link>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">recombinant-mono</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">amino acids 240-251</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">16H22L18</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">rabbit</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">0.5</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Wb, IF</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Thermo Fisher Scientific</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">MA5-41148\n<xref rid=\"tfn2\" ref-type=\"table-fn\">**</xref>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">XH3670137</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">\n<ext-link xlink:href=\"https://antibodyregistry.org/search?q=AB_2898902\" ext-link-type=\"uri\">AB_2898902</ext-link>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">recombinant-mono</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">C-terminal </td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">SC0536</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">rabbit</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">1.0</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Wb</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Thermo Fisher Scientific</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">MA5-15852\n<xref rid=\"tfn1\" ref-type=\"table-fn\">*</xref>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">XH3669852</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">\n<ext-link xlink:href=\"https://antibodyregistry.org/search?q=AB_11153583\" ext-link-type=\"uri\">AB_11153583</ext-link>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">monoclonal</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">recombinant fragment</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">1H4</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">mouse</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">n/a</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Wb</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Bio-Techne</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">MAB41441\n<xref rid=\"tfn1\" ref-type=\"table-fn\">*</xref>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">ZRQ0318021</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">\n<ext-link xlink:href=\"https://antibodyregistry.org/search?q=AB_2289763\" ext-link-type=\"uri\">AB_2289763</ext-link>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">monoclonal</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">recombinant fragment</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">395004</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">rat</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">5.0</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Wb</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Bio-Techne</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">NB110-60531\n<xref rid=\"tfn1\" ref-type=\"table-fn\">*</xref>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">COEN01-2</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">\n<ext-link xlink:href=\"https://antibodyregistry.org/search?q=AB_920623\" ext-link-type=\"uri\">AB_920623</ext-link>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">monoclonal</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">proprietary informationn</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">WUE-4</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">mouse</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">1.0</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Wb, IP</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Proteintech</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">18254-1-AP</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">68183</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">\n<ext-link xlink:href=\"https://antibodyregistry.org/search?q=AB_2878525\" ext-link-type=\"uri\">AB_2878525</ext-link>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">polyclonal</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">fusion protein Ag13070</td><td colspan=\"1\" rowspan=\"1\"/><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">rabbit</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">0.4</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Wb</td></tr><tr><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Proteintech</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">66830-1-Ig\n<xref rid=\"tfn1\" ref-type=\"table-fn\">*</xref>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">10008911</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">\n<ext-link xlink:href=\"https://antibodyregistry.org/search?q=AB_2882173\" ext-link-type=\"uri\">AB_2882173</ext-link>\n</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">monoclonal</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">fusion protein Ag28186</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">1B2C9</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">mouse</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">2.1</td><td align=\"left\" colspan=\"1\" rowspan=\"1\" valign=\"middle\">Wb, IF</td></tr></tbody></table>\n"}, "text": "Company\tCatalog number\tLot number\tRRID (Antibody Registry)\tClonality\tImmunogenic region\tClone ID\tHost\tConcentration (\u03bcg/\u03bcL)\tVendors recommended applications\t \tGeneTex\tGTX635889\t \t*\t44195\tAB_2909916\tmonoclonal\tproprietary information\tGT27711\tmouse\t1.0\tWb\t \tGeneTex\tGTX635891\t \t*\t44195\tAB_2909917\tmonoclonal\tproprietary information\tGT1627\tmouse\t1.0\tWb\t \tAbcam\tab52607\t \t**\tGR33789797\tAB_867704\trecombinant-mono\tproprietary information\tEP1374Y\trabbit\t0.1\tWb, IP, IF\t \tAbcam\tab51015\t \t**\tGR19880919\tAB_867703\trecombinant-mono\tproprietary information\tEP1373Y\trabbit\t0.14\tWb, IP, IF\t \tAbcam\tab1907\t \t*\tGR33619625\tAB_302669\tmonoclonal\tpolymorphic amino acid 158\tE6D7\tmouse\t1.0\tIF\t \tCell Signaling Technology\t13366\t \t**\t4\tAB_2798191\trecombinant-mono\tproprietary information\tD7I9N\trabbit\tn/a\tWb, IP, IF\t \tAviva Systems Biology\tARP54283\tQC56479-160608\tAB_10640958\tpolyclonal\tN-terminal \t-\trabbit\t0.5\tWb\t \tThermo Fisher Scientific\t701241\t \t**\t2477346\tAB_2532438\trecombinant-mono\tamino acids 240-251\t16H22L18\trabbit\t0.5\tWb, IF\t \tThermo Fisher Scientific\tMA5-41148\t \t**\tXH3670137\tAB_2898902\trecombinant-mono\tC-terminal \tSC0536\trabbit\t1.0\tWb\t \tThermo Fisher Scientific\tMA5-15852\t \t*\tXH3669852\tAB_11153583\tmonoclonal\trecombinant fragment\t1H4\tmouse\tn/a\tWb\t \tBio-Techne\tMAB41441\t \t*\tZRQ0318021\tAB_2289763\tmonoclonal\trecombinant fragment\t395004\trat\t5.0\tWb\t \tBio-Techne\tNB110-60531\t \t*\tCOEN01-2\tAB_920623\tmonoclonal\tproprietary informationn\tWUE-4\tmouse\t1.0\tWb, IP\t \tProteintech\t18254-1-AP\t68183\tAB_2878525\tpolyclonal\tfusion protein Ag13070\t\trabbit\t0.4\tWb\t \tProteintech\t66830-1-Ig\t \t*\t10008911\tAB_2882173\tmonoclonal\tfusion protein Ag28186\t1B2C9\tmouse\t2.1\tWb, IF\t \t", "sentences": [], "annotations": [], "relations": []}, {"offset": 5468, "infons": {"file": "T2.xml", "id": "T2", "section_type": "TABLE", "type": "table_foot"}, "text": "Wb=Western Blot; IF=immunofluorescence; IP=immunoprecipitation.", "sentences": [], "annotations": [], "relations": []}, {"offset": 5532, "infons": {"file": "T2.xml", "id": "T2", "section_type": "TABLE", "type": "table_footnote"}, "text": "Monoclonal antibody.", "sentences": [], "annotations": [], "relations": []}, {"offset": 5553, "infons": {"file": "T2.xml", "id": "T2", "section_type": "TABLE", "type": "table_footnote"}, "text": "Recombinant antibody.", "sentences": [], "annotations": [], "relations": []}, {"offset": 5575, "infons": {"file": "f1000research-12-156691-g0000.jpg", "id": "f1", "section_type": "FIG", "type": "fig_title_caption"}, "text": "Apolipoprotein E antibody screening by Western Blot on culture media.", "sentences": [], "annotations": [], "relations": []}, {"offset": 5645, "infons": {"file": "f1000research-12-156691-g0000.jpg", "id": "f1", "section_type": "FIG", "type": "fig_caption"}, "text": "HAP1 WT and\nAPOE KO were cultured in serum free media. Media were collected, concentrated, and 30 \u03bcg of protein were processed for Western Blot with the indicated Apolipoprotein E antibodies. The Ponceau stained transfers of each blot are shown. Antibody dilutions were chosen according to the recommendations of the antibody supplier. Exceptions were given for antibodies ab1907*,13366**,18254-1-AP, MA5-15852* and 66830-1-Ig* which were titrated to the concentrations listed below, as the signals were too weak when following the supplier\u2019s recommendations. Antibody dilutions used: GTX635889* at 1/200, GTX635891* at 1/200, ab52607** at 1/200, ab51015** at 1/1000, ab1907* at 1/200, 13366** at 1/500, ARP54283 at 1/1000, 701241** at 1/200, MA5-41148** at 1/200, MA5-15852* at 1/200, MAB41441* at 1/200, NB110-60531* at 1/200, 18254-1-AP at 1/200, 66830-1-Ig* at 1/200. Apolipoprotein E predicted band size: 36 kDa. *Monoclonal antibody, **Recombinant antibody.", "sentences": [], "annotations": [], "relations": []}, {"offset": 6612, "infons": {"file": "f1000research-12-156691-g0001.jpg", "id": "f2", "section_type": "FIG", "type": "fig_title_caption"}, "text": "Apolipoprotein E antibody screening by immunoprecipitation on culture media.", "sentences": [], "annotations": [], "relations": []}, {"offset": 6689, "infons": {"file": "f1000research-12-156691-g0001.jpg", "id": "f2", "section_type": "FIG", "type": "fig_caption"}, "text": "Immunoprecipitation was performed on 0.9 mg concentrated culture media from HAP1 WT, and using 2.0 \u03bcg of the indicated Apolipoprotein E antibodies pre-coupled to protein G or protein A magnetic beads. Samples were washed and processed for Western Blot with the indicated Apolipoprotein E antibody. Antibody 13366** was used at 1/500 for all Western Blots. The Ponceau stained transfers of each blot are shown. SM=3% starting material; UB=3% unbound fraction; IP=immunoprecipitate; HC=heavy chain; *Monoclonal antibody, **Recombinant antibody.", "sentences": [], "annotations": [], "relations": []}, {"offset": 7233, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "In conclusion, we have screened Apolipoprotein E commercial antibodies by Western Blot and immunoprecipitation and identified several high-quality antibodies under our standardized experimental conditions. The underlying data was previously uploaded to an open access repository, Zenodo.    ,    ", "sentences": [], "annotations": [], "relations": []}, {"offset": 7530, "infons": {"section_type": "METHODS", "type": "title_1"}, "text": "Methods", "sentences": [], "annotations": [], "relations": []}, {"offset": 7538, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "Antibodies", "sentences": [], "annotations": [], "relations": []}, {"offset": 7549, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "All Apolipoprotein E antibodies are listed in Table 2, together with their corresponding Research Resource Identifiers (RRID), to ensure the antibodies are cited properly.    All antibodies tested detect Human ApoE. Peroxidase-conjugated goat anti-mouse and anti-rabbit antibodies are from Thermo Fisher Scientific (cat. number 65-6520 and 62-6120).", "sentences": [], "annotations": [], "relations": []}, {"offset": 7899, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "Cell culture", "sentences": [], "annotations": [], "relations": []}, {"offset": 7912, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "HAP1 WT and APOE KO cell lines used are listed in Table 1, together with their corresponding RRID, to ensure the cell lines are cited properly.    Cells were cultured in DMEM high-glucose (GE Healthcare cat. number SH30081.01) containing 10% fetal bovine serum (Wisent, cat. number 080450), 2 mM L-glutamate (Wisent cat. number 609065), 100 IU penicillin and 100 \u03bcg/mL streptomycin (Wisent cat. number 450201). Cells were starved in DMEM high-glucose containing L-glutamate and penicillin/streptomycin.", "sentences": [], "annotations": [], "relations": []}, {"offset": 8416, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "Antibody screening by Western Blot on culture media", "sentences": [], "annotations": [], "relations": []}, {"offset": 8468, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "HAP1 cells WT and APOE KO were washed 3\u00d7 with PBS 1\u00d7 and starved for ~18 hrs. Culture media were collected and centrifuged for 10 min at 500\u00d7 g to eliminate cells and larger contaminants, then for 10 min at 4500\u00d7 g to eliminate smaller contaminants. Culture media were concentrated by centrifuging at 4000\u00d7 g for 30 min using Amicon Ultra-15 Centrifugal Filter Units with a membrane NMWL of 10 kDa (MilliporeSigma cat. number UFC901024).", "sentences": [], "annotations": [], "relations": []}, {"offset": 8911, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "Western Blots were performed as described in our standard operating procedure.    Midi precast 4-20% Tris-Glycine polyacrylamide gels from Thermo Fisher Scientific (cat. number WXP42012BOX) were used and proteins were transferred on nitrocellulose membranes. Proteins on the blots were visualized with Ponceau S staining (Thermo Fisher Scientific, cat. number BP103-10) which is scanned to show together with individual Western Blot. Blots were blocked with 5% milk for 1 hr, and antibodies were incubated overnight at 4\u00b0C with 5% bovine serum albumin (BSA) (Wisent, cat. number 800-095) in TBS with 0.1% Tween 20 (TBST) (Cell Signaling Technology, cat. number 9997). Following three washes with TBST, the peroxidase conjugated secondary antibody was incubated at a dilution of ~0.2 \u03bcg/mL in TBST with 5% milk for 1 hr at room temperature followed by three washes with TBST. Membranes were incubated with Pierce ECL from Thermo Fisher Scientific (cat. number 32106) or with Clarity Western ECL Substrate from Bio-Rad (cat. number 1705061) prior to detection with the iBright\u2122 CL1500 Imaging System from Thermo Fisher Scientific (cat. number A44240).", "sentences": [], "annotations": [], "relations": []}, {"offset": 10065, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "Antibody screening by immunoprecipitation on culture media", "sentences": [], "annotations": [], "relations": []}, {"offset": 10124, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "Immunoprecipitation was performed as described in our standard operating procedure.    Antibody-bead conjugates were prepared by adding 2 \u03bcg or 20 \u03bcL of antibody at an unknown concentration to 500 \u03bcL of Pierce IP Lysis Buffer from Thermo Fisher Scientific (cat. number 87788) in a 1.5 mL microcentrifuge tube, together with 30 \u03bcL of Dynabeads protein G - (for Mouse and rat antibodies) and protein A - (for rabbit antibodies) from Thermo Fisher Scientific (cat. number 10003D and 10002D, respectively). Pierce IP Lysis Buffer (25 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-40 and 5% glycerol) was supplemented with the Halt Protease Inhibitor Cocktail 100X from Thermo Fisher Scientific (cat. number 78446) at a final concentration of 1\u00d7. Tubes were rocked for ~1 hr at 4\u00b0C followed by two washes to remove unbound antibodies. Starved HAP1 WT culture media were concentrated as described above. 0.6 mL aliquots at 1.5 mg/L of protein were incubated with an antibody-bead conjugate for ~1 hr at 4\u00b0C. The unbound fractions were collected, and beads were subsequently washed three times with 1.0 mL of IP Lysis Buffer and processed for SDS-PAGE and Western Blot on precast midi 4-20% Tris-Glycine polyacrylamide gels. Prot-A: HRP (MilliporeSigma, cat. number P8651) was used as a secondary detection system at a concentration 0.4 \u03bcg/mL.", "sentences": [], "annotations": [], "relations": []}, {"offset": 11473, "infons": {"section_type": "SUPPL", "type": "title_1"}, "text": "Data availability", "sentences": [], "annotations": [], "relations": []}, {"offset": 11491, "infons": {"section_type": "SUPPL", "type": "paragraph"}, "text": "Zenodo: Antibody Characterization Report for Apolipoprotein E, https://doi.org/10.5281/zenodo.7249055.    ", "sentences": [], "annotations": [], "relations": []}, {"offset": 11598, "infons": {"section_type": "SUPPL", "type": "paragraph"}, "text": "Zenodo: Dataset for the Apolipoprotein E antibody screening study, https://doi.org/10.5281/zenodo.7802875.    ", "sentences": [], "annotations": [], "relations": []}, {"offset": 11709, "infons": {"section_type": "REF", "type": "title"}, "text": "References", "sentences": [], "annotations": [], "relations": []}, {"offset": 11720, "infons": {"fpage": "507", "lpage": "537", "name_0": "surname:Mahley;given-names:RW", "name_1": "surname:Rall;given-names:SC;suffix:Jr", "pub-id_doi": "10.1146/annurev.genom.1.1.507", "pub-id_pmid": "11701639", "section_type": "REF", "source": "\nAnnu. Rev. Genomics Hum. Genet.\n", "type": "ref", "volume": "1", "year": "2000"}, "text": "Apolipoprotein E: far more than a lipid transport protein.", "sentences": [], "annotations": [], "relations": []}, {"offset": 11779, "infons": {"fpage": "1959", "issue": "17", "lpage": "1968", "name_0": "surname:Mann;given-names:KM", "name_1": "surname:Thorngate;given-names:FE", "name_2": "surname:Katoh-Fukui;given-names:Y", "pub-id_doi": "10.1093/hmg/ddh199", "pub-id_pmid": "15229191", "section_type": "REF", "source": "\nHum. Mol. Genet.\n", "type": "ref", "volume": "13", "year": "2004"}, "text": "Independent effects of APOE on cholesterol metabolism and brain Abeta levels in an Alzheimer disease mouse model.", "sentences": [], "annotations": [], "relations": []}, {"offset": 11893, "infons": {"fpage": "222", "issue": "2", "lpage": "226", "name_0": "surname:Yamamoto;given-names:T", "name_1": "surname:Choi;given-names:HW", "name_2": "surname:Ryan;given-names:RO", "pub-id_doi": "10.1016/j.ab.2007.09.005", "pub-id_pmid": "17923100", "section_type": "REF", "source": "\nAnal. Biochem.\n", "type": "ref", "volume": "372", "year": "2008"}, "text": "Apolipoprotein E isoform-specific binding to the low-density lipoprotein receptor.", "sentences": [], "annotations": [], "relations": []}, {"offset": 11976, "infons": {"fpage": "310", "issue": "4", "lpage": "315", "name_0": "surname:Menzel;given-names:H", "name_1": "surname:Kladetzky;given-names:R", "name_2": "surname:Assmann;given-names:G", "pub-id_doi": "10.1161/01.ATV.3.4.310", "pub-id_pmid": "6882285", "section_type": "REF", "source": "\nArteriosclerosis.\n", "type": "ref", "volume": "3", "year": "1983"}, "text": "Apolipoprotein E polymorphism and coronary artery disease.", "sentences": [], "annotations": [], "relations": []}, {"offset": 12035, "infons": {"fpage": "265", "issue": "2", "lpage": "269", "name_0": "surname:Steng\u00e5rd;given-names:JH", "name_1": "surname:Zerba;given-names:KE", "name_2": "surname:Pekkanen;given-names:J", "pub-id_doi": "10.1161/01.CIR.91.2.265", "pub-id_pmid": "7805227", "section_type": "REF", "source": "\nCirculation.\n", "type": "ref", "volume": "91", "year": "1995"}, "text": "Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men.", "sentences": [], "annotations": [], "relations": []}, {"offset": 12156, "infons": {"fpage": "921", "issue": "5123", "lpage": "923", "name_0": "surname:Corder;given-names:EH", "name_1": "surname:Saunders;given-names:AM", "name_2": "surname:Strittmatter;given-names:WJ", "pub-id_doi": "10.1126/science.8346443", "pub-id_pmid": "8346443", "section_type": "REF", "source": "\nScience.\n", "type": "ref", "volume": "261", "year": "1993"}, "text": "Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families.", "sentences": [], "annotations": [], "relations": []}, {"offset": 12262, "infons": {"fpage": "1977", "issue": "5", "lpage": "1981", "name_0": "surname:Strittmatter;given-names:WJ", "name_1": "surname:Saunders;given-names:AM", "name_2": "surname:Schmechel;given-names:D", "pub-id_doi": "10.1073/pnas.90.5.1977", "pub-id_pmid": "8446617", "section_type": "REF", "source": "\nProc. Natl. Acad. Sci.\n", "type": "ref", "volume": "90", "year": "1993"}, "text": "Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.", "sentences": [], "annotations": [], "relations": []}, {"offset": 12400, "infons": {"fpage": "E1033", "issue": "35", "lpage": "E1041", "name_0": "surname:Rasmussen;given-names:KL", "name_1": "surname:Tybj\u00e6rg-Hansen;given-names:A", "name_2": "surname:Nordestgaard;given-names:BG", "pub-id_doi": "10.1503/cmaj.180066", "pub-id_pmid": "30181149", "section_type": "REF", "source": "\nCMAJ.\n", "type": "ref", "volume": "190", "year": "2018"}, "text": "Absolute 10-year risk of dementia by age, sex and APOE genotype: a population-based cohort study.", "sentences": [], "annotations": [], "relations": []}, {"offset": 12498, "infons": {"fpage": "8", "name_0": "surname:Laflamme;given-names:C", "name_1": "surname:McKeever;given-names:PM", "name_2": "surname:Kumar;given-names:R", "pub-id_doi": "10.7554/eLife.48363", "section_type": "REF", "source": "\nelife.\n", "type": "ref", "volume": "8", "year": "2019"}, "text": "Implementation of an antibody characterization procedure and application to the major ALS/FTD disease gene C9ORF72.", "sentences": [], "annotations": [], "relations": []}, {"offset": 12614, "infons": {"fpage": "148", "issue": "12", "name_0": "surname:Ayoubi;given-names:R", "name_1": "surname:Southern;given-names:K", "name_2": "surname:Laflamme;given-names:C", "section_type": "REF", "source": "\nF1000Res.\n", "type": "ref", "volume": "2023", "year": "2023"}, "text": "The identification of high-performing antibodies for Midkine for use in Western blot and immunoprecipitation [version 1; peer review: awaiting peer review].", "sentences": [], "annotations": [], "relations": []}, {"offset": 12771, "infons": {"fpage": "291", "name_0": "surname:Ayoubi;given-names:R", "name_1": "surname:Southern;given-names:K", "name_2": "surname:Laflamme;given-names:C", "pub-id_doi": "10.12688/f1000research.130991.1", "section_type": "REF", "source": "\nF1000Res.\n", "type": "ref", "volume": "12", "year": "2023"}, "text": "The identification of high-performing antibodies for Secreted frizzled-related protein 1 (sFRP-1) for use in Western Blot and immunoprecipitation [version 1; peer review: awaiting peer review].", "sentences": [], "annotations": [], "relations": []}, {"offset": 12965, "infons": {"name_0": "surname:Ayoubi;given-names:R", "name_1": "surname:McPherson;given-names:PS", "name_2": "surname:Laflamme;given-names:C", "pub-id_doi": "10.5281/zenodo.7249055", "section_type": "REF", "type": "ref", "year": "2022"}, "text": "Antibody Characterization Report for Apolipoprotein E.", "sentences": [], "annotations": [], "relations": []}, {"offset": 13020, "infons": {"name_0": "surname:Laflamme;given-names:C", "pub-id_doi": "10.5281/zenodo.7802875", "section_type": "REF", "source": "\nZenodo.\n", "type": "ref", "year": "2023"}, "text": "", "sentences": [], "annotations": [], "relations": []}, {"offset": 13021, "infons": {"fpage": "D358", "issue": "D1", "lpage": "D367", "name_0": "surname:Bandrowski;given-names:A", "name_1": "surname:Pairish;given-names:M", "name_2": "surname:Eckmann;given-names:P", "pub-id_doi": "10.1093/nar/gkac927", "pub-id_pmid": "36370112", "section_type": "REF", "source": "\nNucleic Acids Res.\n", "type": "ref", "volume": "51", "year": "2023"}, "text": "The Antibody Registry: ten years of registering antibodies.", "sentences": [], "annotations": [], "relations": []}, {"offset": 13081, "infons": {"fpage": "25", "issue": "2", "lpage": "38", "name_0": "surname:Bairoch;given-names:A", "pub-id_doi": "10.7171/jbt.18-2902-002", "pub-id_pmid": "29805321", "section_type": "REF", "source": "\nJ. Biomol. Tech.\n", "type": "ref", "volume": "29", "year": "2018"}, "text": "The Cellosaurus, a Cell-Line Knowledge Resource.", "sentences": [], "annotations": [], "relations": []}, {"offset": 13130, "infons": {"name_0": "surname:Ayoubi;given-names:R", "name_1": "surname:McPherson;given-names:PS", "name_2": "surname:Laflamme;given-names:C", "pub-id_doi": "10.5281/zenodo.5717510", "section_type": "REF", "type": "ref", "year": "2021"}, "text": "Antibody Screening by Immunoblot.", "sentences": [], "annotations": [], "relations": []}, {"offset": 13164, "infons": {"name_0": "surname:Ayoubi;given-names:R", "name_1": "surname:Fotouhi;given-names:M", "name_2": "surname:McPherson;given-names:P", "pub-id_doi": "10.5281/zenodo.5717516", "section_type": "REF", "type": "ref", "year": "2021"}, "text": "Antibody screening by Immunoprecitation.", "sentences": [], "annotations": [], "relations": []}, {"offset": 13205, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "10.5256/f1000research.156691.r228353", "sentences": [], "annotations": [], "relations": []}, {"offset": 13242, "infons": {"section_type": "REF", "type": "title"}, "text": "Reviewer response for version 3", "sentences": [], "annotations": [], "relations": []}, {"offset": 13274, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Leoni", "sentences": [], "annotations": [], "relations": []}, {"offset": 13280, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Valerio", "sentences": [], "annotations": [], "relations": []}, {"offset": 13288, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "2023", "sentences": [], "annotations": [], "relations": []}, {"offset": 13293, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.", "sentences": [], "annotations": [], "relations": []}, {"offset": 13532, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "The manuscript Identification of high-performing antibodies for Apolipoprotein E for use in Western Blot and immunoprecipitation by Riham Ayoubi study the quality of commercial Anti-Apolipoporterin E antibodies.", "sentences": [], "annotations": [], "relations": []}, {"offset": 13744, "infons": {"section_type": "REF", "type": "paragraph"}, "text": " The Apolipoprotein E is involved in lipid distribution and metabolism among cells, especially in the CNS. The dysregulation of Apolipoprotein E can disturb cholesterol homeostasis, resulting in several diseases, including cardiovascular disease and Alzheimer\u2019s disease. Provide high-quality antibodies for this protein to the scientific community is very important. They characterized fourteen Apolipoprotein E commercial antibodies for Western Blot and immunoprecipitation, using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls.", "sentences": [], "annotations": [], "relations": []}, {"offset": 14349, "infons": {"section_type": "REF", "type": "paragraph"}, "text": " The study was well planned and interesting.", "sentences": [], "annotations": [], "relations": []}, {"offset": 14394, "infons": {"section_type": "REF", "type": "paragraph"}, "text": " Results are clear,", "sentences": [], "annotations": [], "relations": []}, {"offset": 14414, "infons": {"section_type": "REF", "type": "paragraph"}, "text": " Figure and table informative", "sentences": [], "annotations": [], "relations": []}, {"offset": 14444, "infons": {"section_type": "REF", "type": "paragraph"}, "text": " A minor linguistic revision is recommended", "sentences": [], "annotations": [], "relations": []}, {"offset": 14488, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Are sufficient details of methods and materials provided to allow replication by others?", "sentences": [], "annotations": [], "relations": []}, {"offset": 14577, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Yes", "sentences": [], "annotations": [], "relations": []}, {"offset": 14581, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Is the rationale for creating the dataset(s) clearly described?", "sentences": [], "annotations": [], "relations": []}, {"offset": 14645, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Yes", "sentences": [], "annotations": [], "relations": []}, {"offset": 14649, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Are the datasets clearly presented in a useable and accessible format?", "sentences": [], "annotations": [], "relations": []}, {"offset": 14720, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Yes", "sentences": [], "annotations": [], "relations": []}, {"offset": 14724, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Are the protocols appropriate and is the work technically sound?", "sentences": [], "annotations": [], "relations": []}, {"offset": 14789, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Yes", "sentences": [], "annotations": [], "relations": []}, {"offset": 14793, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Reviewer Expertise:", "sentences": [], "annotations": [], "relations": []}, {"offset": 14813, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Lipidomics and metabolomics", "sentences": [], "annotations": [], "relations": []}, {"offset": 14841, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.", "sentences": [], "annotations": [], "relations": []}, {"offset": 15062, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "10.5256/f1000research.153492.r201058", "sentences": [], "annotations": [], "relations": []}, {"offset": 15099, "infons": {"section_type": "REF", "type": "title"}, "text": "Reviewer response for version 2", "sentences": [], "annotations": [], "relations": []}, {"offset": 15131, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Macrez", "sentences": [], "annotations": [], "relations": []}, {"offset": 15138, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Nathalie", "sentences": [], "annotations": [], "relations": []}, {"offset": 15147, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "2023", "sentences": [], "annotations": [], "relations": []}, {"offset": 15152, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.", "sentences": [], "annotations": [], "relations": []}, {"offset": 15391, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "The title states \"identification of high performing antibodies for APOE\" - the authors indeed present some data supporting such identification but lack any interpretation of these data. Even if the authors have already answered the first reviewer about this point, the YCharOS gateway does not hinder the interpretation of results useful for the scientific community. Interpretation and limits of interpretation of the results are required and crucial for using this \"report as a guide to select the most appropriate antibody for their specific needs\" as stated in the abstract. The authors could give clear interpretations of their WB and IP results in terms of efficiency, specificity and potential use of these antibodies (e.g.: suitable or not for full-length APOE protein identification in WB; not suitable for immuno because recognized unspecific bands; suitable or not for identification of fragments; suitable or not for immunoprecipitation of APOE...).", "sentences": [], "annotations": [], "relations": []}, {"offset": 16353, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "To better understand the scope of application of the results presented in this paper, it is necessary to understand which forms of APOE are present in the cellular models studied. Which isoforms of APOE are expressed in these human cell-derived cell lines? Did the authors check the efficiency of the tested antibodies for the 3 APOE isoforms? Are these cell lines suitable for studying the cleaved forms of APOE?", "sentences": [], "annotations": [], "relations": []}, {"offset": 16767, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Figure 1: As the legend states, \"exceptions were given for some antibodies as the signals were too weak when following the supplier\u2019s recommendations\u201d. For the same reasons as done for antibodies 13366**,18254-1-AP and 66830-1-Ig*, why were the titration of ab1907* and MA5-15852* not increased? Could the low antibody titration explain the lack of APOE detection by ab1907* and MA5-15852*?", "sentences": [], "annotations": [], "relations": []}, {"offset": 17162, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Could the authors explain why they chose 13366** for western blotting after IP? Did they use other antibodies for this purpose, if yes, were the results similar?", "sentences": [], "annotations": [], "relations": []}, {"offset": 17324, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "The authors have compared commercially available apolipoprotein E antibodies for detection by Western blotting and immunoprecipitation using HAP1 cells expressing APOE and their KO counterparts lacking APOE. The resource is helpful but it lacks some information for full interpretation. It could be improved by addressing the following:  ", "sentences": [], "annotations": [], "relations": []}, {"offset": 17663, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Are sufficient details of methods and materials provided to allow replication by others?", "sentences": [], "annotations": [], "relations": []}, {"offset": 17752, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Yes", "sentences": [], "annotations": [], "relations": []}, {"offset": 17756, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Is the rationale for creating the dataset(s) clearly described?", "sentences": [], "annotations": [], "relations": []}, {"offset": 17820, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Yes", "sentences": [], "annotations": [], "relations": []}, {"offset": 17824, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Are the datasets clearly presented in a useable and accessible format?", "sentences": [], "annotations": [], "relations": []}, {"offset": 17895, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Yes", "sentences": [], "annotations": [], "relations": []}, {"offset": 17899, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Are the protocols appropriate and is the work technically sound?", "sentences": [], "annotations": [], "relations": []}, {"offset": 17964, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Partly", "sentences": [], "annotations": [], "relations": []}, {"offset": 17971, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Reviewer Expertise:", "sentences": [], "annotations": [], "relations": []}, {"offset": 17991, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "neurobiology, APOE protein biochemistry, immunochemistry", "sentences": [], "annotations": [], "relations": []}, {"offset": 18048, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.", "sentences": [], "annotations": [], "relations": []}, {"offset": 18269, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Southern", "sentences": [], "annotations": [], "relations": []}, {"offset": 18278, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Kathleen", "sentences": [], "annotations": [], "relations": []}, {"offset": 18287, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "2023", "sentences": [], "annotations": [], "relations": []}, {"offset": 18292, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Dear Nathalie Macrez,", "sentences": [], "annotations": [], "relations": []}, {"offset": 18314, "infons": {"section_type": "REF", "type": "paragraph"}, "text": " We\u2019d first like to thank you for taking the time to generate an in-depth review of our antibody characterization study for Apolipoprotein E. Your feedback and suggestions are appreciated as we are always looking to improve our methods and ensure our goals are clear and aligned.", "sentences": [], "annotations": [], "relations": []}, {"offset": 18596, "infons": {"section_type": "REF", "type": "paragraph"}, "text": " To address your first point, YCharOS is funded by various granting agencies that nominate proteins for their desired disease. We\u2019re not experts of these proteins and prefer to remain impartial which is why we carry out the study without interpreting the results. The purpose of YCharOS is to deliver antibody characterization reports as a public good collection to benefit biomedical research as a whole. It is for this reason that we chose to publish our articles using the Data Note format, as it does not require result analysis but rather presents KO characterization data for experts of the individual targets to further their studies and projects.", "sentences": [], "annotations": [], "relations": []}, {"offset": 19253, "infons": {"section_type": "REF", "type": "paragraph"}, "text": " To your second point, we used DepMap, a transcriptomics database and identified wild type (WT) HAP1 as a suitable cell line as it expressed the full APOE transcript at a level greater than our pre-determined cut-off. An APOE knockout (KO) equivalent of the HAP1 cell line was purchased. Although the authors comprise of a team of experts in antibody characterization for the 3 tested applications, they are not ApoE experts and don\u2019t know all ApoE cleaved fragments. We do know that the signals which disappear in the KO line are ApoE species. If an ApoE researcher was interested in testing the antibodies for specific isoform, we would suggest creating or purchasing a KO line for the desired ApoE isoform and see whether the signal is lost in the KO lysate compared to the WT.", "sentences": [], "annotations": [], "relations": []}, {"offset": 20036, "infons": {"section_type": "REF", "type": "paragraph"}, "text": " The Western blot analysis was repeated for ab1907* and MA5-15852* where both antibodies were tested at 1/200 rather than 1/1000. The results and figure legend will be adjusted and a third version will be submitted to F1000. Please note that, to begin with, Western blot is not a recommended application for ab1907, \u00a0which is why we did not increase the titration of the antibody in the original analysis.", "sentences": [], "annotations": [], "relations": []}, {"offset": 20443, "infons": {"section_type": "REF", "type": "paragraph"}, "text": " For immunoprecipitation, the performance of each antibody is evaluated using an antibody that specifically immunodetected ApoE in the Western blot. The 13366* antibody was able to detect both of the most prominent ApoE isoforms with high specificity, which is why it was chosen for IP.", "sentences": [], "annotations": [], "relations": []}, {"offset": 20730, "infons": {"section_type": "REF", "type": "paragraph"}, "text": " We hope we have answered all of your questions and concerns in this reply as well as the new version which has recently been submitted to F1000.", "sentences": [], "annotations": [], "relations": []}, {"offset": 20876, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "10.5256/f1000research.153492.r190833", "sentences": [], "annotations": [], "relations": []}, {"offset": 20913, "infons": {"section_type": "REF", "type": "title"}, "text": "Reviewer response for version 2", "sentences": [], "annotations": [], "relations": []}, {"offset": 20945, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Kritharides", "sentences": [], "annotations": [], "relations": []}, {"offset": 20957, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Leonard", "sentences": [], "annotations": [], "relations": []}, {"offset": 20965, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Kockx", "sentences": [], "annotations": [], "relations": []}, {"offset": 20971, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Maaike", "sentences": [], "annotations": [], "relations": []}, {"offset": 20978, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "2023", "sentences": [], "annotations": [], "relations": []}, {"offset": 20983, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.", "sentences": [], "annotations": [], "relations": []}, {"offset": 21222, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "We are happy with the response and approve of the article.", "sentences": [], "annotations": [], "relations": []}, {"offset": 21281, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Are sufficient details of methods and materials provided to allow replication by others?", "sentences": [], "annotations": [], "relations": []}, {"offset": 21370, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Yes", "sentences": [], "annotations": [], "relations": []}, {"offset": 21374, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Is the rationale for creating the dataset(s) clearly described?", "sentences": [], "annotations": [], "relations": []}, {"offset": 21438, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Yes", "sentences": [], "annotations": [], "relations": []}, {"offset": 21442, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Are the datasets clearly presented in a useable and accessible format?", "sentences": [], "annotations": [], "relations": []}, {"offset": 21513, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Yes", "sentences": [], "annotations": [], "relations": []}, {"offset": 21517, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Are the protocols appropriate and is the work technically sound?", "sentences": [], "annotations": [], "relations": []}, {"offset": 21582, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Yes", "sentences": [], "annotations": [], "relations": []}, {"offset": 21586, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Reviewer Expertise:", "sentences": [], "annotations": [], "relations": []}, {"offset": 21606, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Cell biology and biochemistry of apo E", "sentences": [], "annotations": [], "relations": []}, {"offset": 21645, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "We confirm that we have read this submission and believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.", "sentences": [], "annotations": [], "relations": []}, {"offset": 21809, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "10.5256/f1000research.146914.r186248", "sentences": [], "annotations": [], "relations": []}, {"offset": 21846, "infons": {"section_type": "REF", "type": "title"}, "text": "Reviewer response for version 1", "sentences": [], "annotations": [], "relations": []}, {"offset": 21878, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Kritharides", "sentences": [], "annotations": [], "relations": []}, {"offset": 21890, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Leonard", "sentences": [], "annotations": [], "relations": []}, {"offset": 21898, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Kockx", "sentences": [], "annotations": [], "relations": []}, {"offset": 21904, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Maaike", "sentences": [], "annotations": [], "relations": []}, {"offset": 21911, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "2023", "sentences": [], "annotations": [], "relations": []}, {"offset": 21916, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.", "sentences": [], "annotations": [], "relations": []}, {"offset": 22155, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Provide a summary and conclusion commenting on which antibodies are recommended for either Western Blotting or Immunoprecipitation.", "sentences": [], "annotations": [], "relations": []}, {"offset": 22287, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "ApoE can be cleaved generating a C-terminal and a N-terminal peptide. The current work does not investigate whether the antibodies tested detect these cleavage products. Please state the immunogenic region to which the antibodies are raised in table 2.", "sentences": [], "annotations": [], "relations": []}, {"offset": 22540, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Please add details about species specificity to Table 2. If all detect human apoE please make this explicit.", "sentences": [], "annotations": [], "relations": []}, {"offset": 22649, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Cellular apoE exists as non-glycosylated and glycosylated isoforms, and secreted apoE is variably but predominantly glycosylated (refs 1-3). The authors have only shown detection of secreted apoE. It would be helpful to show the ability of the antibodies to detect cellular apoE glycoforms. This will also indicate whether the antibodies display non-specific binding to other cellular proteins.", "sentences": [], "annotations": [], "relations": []}, {"offset": 23044, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Provide full name for HAP1 before abbreviation is used.", "sentences": [], "annotations": [], "relations": []}, {"offset": 23100, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "What is the apoE genotype of the HAP1 cell line they have used?", "sentences": [], "annotations": [], "relations": []}, {"offset": 23164, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "The authors have compared and validated commercially available apolipoprotein E antibodies for detection by Western blotting and immunoprecipitation using HAP1 cells with and without apoE expression.The\u00a0resource is helpful and could be improved by addressing the following:  ", "sentences": [], "annotations": [], "relations": []}, {"offset": 23441, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Are sufficient details of methods and materials provided to allow replication by others?", "sentences": [], "annotations": [], "relations": []}, {"offset": 23530, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Yes", "sentences": [], "annotations": [], "relations": []}, {"offset": 23534, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Is the rationale for creating the dataset(s) clearly described?", "sentences": [], "annotations": [], "relations": []}, {"offset": 23598, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Yes", "sentences": [], "annotations": [], "relations": []}, {"offset": 23602, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Are the datasets clearly presented in a useable and accessible format?", "sentences": [], "annotations": [], "relations": []}, {"offset": 23673, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Yes", "sentences": [], "annotations": [], "relations": []}, {"offset": 23677, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Are the protocols appropriate and is the work technically sound?", "sentences": [], "annotations": [], "relations": []}, {"offset": 23742, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Yes", "sentences": [], "annotations": [], "relations": []}, {"offset": 23746, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Reviewer Expertise:", "sentences": [], "annotations": [], "relations": []}, {"offset": 23766, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Cell biology and biochemistry of apo E", "sentences": [], "annotations": [], "relations": []}, {"offset": 23805, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "We confirm that we have read this submission and believe that we have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however we have significant reservations, as outlined above.", "sentences": [], "annotations": [], "relations": []}, {"offset": 24030, "infons": {"section_type": "REF", "type": "title"}, "text": "References", "sentences": [], "annotations": [], "relations": []}, {"offset": 24041, "infons": {"fpage": "9137", "issue": "16", "lpage": "40", "pub-id_pmid": "2498327", "section_type": "REF", "source": "\nJ Biol Chem\n", "type": "ref", "volume": "264", "year": "1989"}, "text": "Expression of ApoE gene in Chinese hamster cells with a reversible defect in O-glycosylation. Glycosylation is not required for apoE secretion.", "sentences": [], "annotations": [], "relations": []}, {"offset": 24185, "infons": {"fpage": "9094", "issue": "15", "lpage": "101", "pub-id_pmid": "2498325", "section_type": "REF", "source": "\nJ Biol Chem\n", "type": "ref", "volume": "264", "year": "1989"}, "text": "Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194.", "sentences": [], "annotations": [], "relations": []}, {"offset": 24277, "infons": {"elocation-id": "10.1074/mcp.M900430-MCP200", "fpage": "1968", "issue": "9", "lpage": "81", "pub-id_doi": "10.1074/mcp.M900430-MCP200", "pub-id_pmid": "20511397", "section_type": "REF", "source": "\nMol Cell Proteomics\n", "type": "ref", "volume": "9", "year": "2010"}, "text": "Glycosylation and sialylation of macrophage-derived human apolipoprotein E analyzed by SDS-PAGE and mass spectrometry: evidence for a novel site of glycosylation on Ser290.", "sentences": [], "annotations": [], "relations": []}, {"offset": 24450, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Southern", "sentences": [], "annotations": [], "relations": []}, {"offset": 24459, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Kathleen", "sentences": [], "annotations": [], "relations": []}, {"offset": 24468, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "2023", "sentences": [], "annotations": [], "relations": []}, {"offset": 24473, "infons": {"section_type": "REF", "type": "paragraph"}, "text": "Thank you to Leonard Kritharides and Maaike Kcokx for your extensive review of this article. We appreciate your constructive feedback and will be submitting a new version of the manuscript, to include several of your suggestions that are within the scope of this study.", "sentences": [], "annotations": [], "relations": []}, {"offset": 24743, "infons": {"section_type": "REF", "type": "paragraph"}, "text": " Unfortunately, we cannot comment or conclude on which antibodies to select for Western Blot and Immunoprecipitation. Previously discussed on the FAQ section of the YCharOS gateway page, we have found that, for the most part, scientists interested in our reports have the expertise to interpret the antibody characterization data. Moreover, as the antibodies are tested under one specific set of conditions, the scoring/recommendation would be valid only under the precise experimental setup and cell line used. That said, YCharOS reports serve as an invaluable guide pointing scientists to select the appropriate antibodies for their experimental needs.", "sentences": [], "annotations": [], "relations": []}, {"offset": 25398, "infons": {"section_type": "REF", "type": "paragraph"}, "text": " As per your second and third points, a column will be added to Table 2 in the newly submitted version of the manuscript to include the immunogenic regions of the commercial antibodies that were tested.\u00a0 We also included a statement in the Antibodies sub-section of the Methods section stating that all antibodies tested were reactive against Human ApoE antigen.", "sentences": [], "annotations": [], "relations": []}, {"offset": 25762, "infons": {"section_type": "REF", "type": "paragraph"}, "text": " As a follow up to your fourth point, our workflow consists of testing antibodies on culture media for secreted proteins - allowing the identification of antibodies with high selectivity for the corresponding protein. We believe our data can be used to inform scientists on the best antibodies to purchase to identify intracellular ApoE. We leave it to experts in the field to optimize antibodies for their own experimental conditions.\u00a0", "sentences": [], "annotations": [], "relations": []}, {"offset": 26200, "infons": {"section_type": "REF", "type": "paragraph"}, "text": " For the final suggestion, we have included in Table 1 that the ApoE KO cell line is derived from a 16bp deletion of ApoE.", "sentences": [], "annotations": [], "relations": []}], "annotations": [], "relations": []}]}]